Literature DB >> 18694342

Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells.

Alfredo Pezzicoli1, Isabella Santi, Peter Lauer, Roberto Rosini, Daniela Rinaudo, Guido Grandi, John L Telford, Marco Soriani.   

Abstract

We have recently shown that group B Streptococcus (GBS) crosses the epithelial barrier by a paracellular route. Here, we show that, although deletion of the pilus backbone protein did not affect GBS adhesiveness, it reduced the pathogen's capacity to transcytose through differentiated human epithelial cells. In addition, contrary to our expectation, a strain with a mutant pilus ancillary protein and reduced adhesiveness translocated through the epithelial monolayer in a fashion identical to that of the isogenic wild-type strain. To monitor the localization of pili during GBS paracytosis, we performed 3-dimensional confocal experiments. By this approach, we observed that pili located in the intercellular space ahead of translocating bacteria. These results were also confirmed by a novel in vitro model of GBS infection in which bacteria bind to epithelial surfaces against the action of gravitation. These findings suggest a dual role for pilus components during the critical steps leading to GBS dissemination in the host.

Entities:  

Mesh:

Year:  2008        PMID: 18694342     DOI: 10.1086/591182

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Regulation and function of pilus island 1 in group B streptococcus.

Authors:  Shengmei Jiang; Su Eun Park; Puja Yadav; Lawrence C Paoletti; Michael R Wessels
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

Review 2.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 3.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

4.  CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Authors:  Isabella Santi; Renata Grifantini; Sheng-Mei Jiang; Cecilia Brettoni; Guido Grandi; Michael R Wessels; Marco Soriani
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

Review 5.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

Review 6.  A hypothetical model of host-pathogen interaction of Streptococcus suis in the gastro-intestinal tract.

Authors:  Maria Laura Ferrando; Constance Schultsz
Journal:  Gut Microbes       Date:  2016

Review 7.  Architects at the bacterial surface - sortases and the assembly of pili with isopeptide bonds.

Authors:  Antoni P A Hendrickx; Jonathan M Budzik; So-Young Oh; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2011-03       Impact factor: 60.633

8.  Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections.

Authors:  Annalisa Nuccitelli; Roberta Cozzi; Louise J Gourlay; Danilo Donnarumma; Francesca Necchi; Nathalie Norais; John L Telford; Rino Rappuoli; Martino Bolognesi; Domenico Maione; Guido Grandi; C Daniela Rinaudo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-18       Impact factor: 11.205

Review 9.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen.

Authors:  Blair Armistead; Elizabeth Oler; Kristina Adams Waldorf; Lakshmi Rajagopal
Journal:  J Mol Biol       Date:  2019-01-31       Impact factor: 5.469

10.  Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus.

Authors:  Cira Daniela Rinaudo; Roberto Rosini; Cesira L Galeotti; Francesco Berti; Francesca Necchi; Valerio Reguzzi; Claudia Ghezzo; John Laird Telford; Guido Grandi; Domenico Maione
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.